patent/RS-53386-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-53386-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate	2007-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ebf97c6ad725d3a9fb21f2a97c0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56854da1b293ab07bfec799d5bbd1feb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb80ca09b3f3fc95d494f978e408883
publicationDate	2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	RS-53386-B
titleOfInvention	NEW INTERMEDIATE AND PROCESS USED IN PRODUCTION {2- [1- (3,5-BI-TRIFLUOROMETHYL-BENZYL) -5-PYRIDIN-4-IL-1H- [1,2,3] TRIAZOL-4-IL] -PYRIDINE -3-IL} - (2-CHLOROPHENYL) -METHANONE
abstract	Process for the preparation of {2- [1- (3,5-bitrifluoromethylbenzyl) -5-pyridin-4-yl-1H- [1,2,3] triazol-4-yl] -pyridin-3-yl} - ( 2-chlorophenyl) -methanone, Form IV, comprising: a product which crystallizes from a solvent mixture of isopropyl acetate and heptane. The application comprises 5 further claims.
priorityDate	2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419676935 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978442 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3587356 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9916461

Total number of triples: 37.